No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs189616568 |
chr6:53918434-53918435 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs9474719 |
chr6:53918458-53918459 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
3 |
rs549902969 |
chr6:53918525-53918526 |
Weak transcription Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs71558853 |
chr6:53918837-53918838 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs145300513 |
chr6:53918888-53918889 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs541463415 |
chr6:53918946-53918947 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs555758150 |
chr6:53919042-53919043 |
Enhancers Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs566379774 |
chr6:53919043-53919044 |
Enhancers Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs149194784 |
chr6:53919051-53919052 |
Enhancers Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs182697106 |
chr6:53919180-53919181 |
Enhancers Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs72955958 |
chr6:53919185-53919186 |
Enhancers Weak transcription Active TSS Flanking Active TSS Flanking Bivalent TSS/Enh
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
12 |
rs148455872 |
chr6:53919218-53919219 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs374597265 |
chr6:53919226-53919227 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs376207103 |
chr6:53919228-53919229 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs370289077 |
chr6:53919229-53919230 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs398001622 |
chr6:53919246-53919247 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs543525880 |
chr6:53919268-53919269 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs557120034 |
chr6:53919286-53919287 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs573649879 |
chr6:53919302-53919303 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs542659414 |
chr6:53919323-53919324 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs188217448 |
chr6:53919324-53919325 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs528390149 |
chr6:53919340-53919341 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs141505279 |
chr6:53919360-53919361 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs576424286 |
chr6:53919400-53919401 |
Enhancers Weak transcription Active TSS Flanking Active TSS Bivalent/Poised TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs16884654 |
chr6:53919407-53919408 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
26 |
rs145278582 |
chr6:53919529-53919530 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs144797331 |
chr6:53919586-53919587 |
Enhancers Weak transcription Flanking Active TSS Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs117318275 |
chr6:53919644-53919645 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs569838400 |
chr6:53919655-53919656 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs546315534 |
chr6:53919690-53919691 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs56830731 |
chr6:53919703-53919704 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs529217655 |
chr6:53919745-53919746 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs549370291 |
chr6:53919767-53919768 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs566198650 |
chr6:53919789-53919790 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs367920305 |
chr6:53919834-53919835 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs558199791 |
chr6:53919847-53919848 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs572169896 |
chr6:53919854-53919855 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs571845195 |
chr6:53919905-53919906 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs537661946 |
chr6:53919927-53919928 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs377359864 |
chr6:53919935-53919936 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs573788223 |
chr6:53919953-53919954 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs192794364 |
chr6:53919961-53919962 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs115738440 |
chr6:53919964-53919965 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs572790181 |
chr6:53919974-53919975 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs185089121 |
chr6:53919978-53919979 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs17631709 |
chr6:53920022-53920023 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs7739196 |
chr6:53920024-53920025 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
48 |
rs138116930 |
chr6:53920042-53920043 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs563403967 |
chr6:53920046-53920047 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs374918235 |
chr6:53920114-53920115 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|